Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)GuruFocus • 23 days ago
Related Stocks: CERE...
Share to Feed
This is a signal that CERE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that CERE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE Get Free Report) Director N Anthony Coles sold 50,000 shares of the companys stock in a transaction that occurred on Monday, March 4th...
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE Get Free Report) has been given an average recommendation of Hold by the eleven ratings firms that are presently covering the...
Investors in Cerevel Therapeutics Holdings Inc (CERE) saw new options become available this week, for the March 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and...
Investors in Cerevel Therapeutics Holdings Inc (CERE) saw new options begin trading this week, for the August 16th expiration. One of the key inputs that goes into the price an option buyer is...
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE Get Free Report) Director N Anthony Coles sold 2,506 shares of Cerevel Therapeutics stock in a transaction dated Wednesday, February 7th. The...
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE Get Free Report) insider John Renger sold 2,161 shares of the firms stock in a transaction that occurred on Wednesday, February 7th...
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Cerevel Therapeutics Holdings Inc (CERE) was identified as having a larger market cap than the smaller...